SYDNEY, OCT 3 - The George Institute for Global Health will receive $902,000 to evaluate the best treatments for aneurysmal subarachnoid haemorrhage, it was announced today.
This condition, which most commonly affects women aged 40 to 60, will lead to the death of one third of all people afflicted. More than half of those who survive will suffer permanent disability. This clinical trial will help doctors better manage patients with this condition.
Authored by Professor Goran Tomson, Distinguished Fellow, Thought Leadership program, The George Institute for Global Health.
Professor Goran Tomson is a leading voice in global health systems research. His remarkable career, first practicing medicine and later research in health system changes to improve quality of care, spans over thirty years and crosses countless borders. In this piece, he reflects on the developments he has observed in Global Health Systems Research and presents his perspectives on challenges and opportunities in the future.
Cardiovascular disease claims the most lives of any illness. Ahead of World Heart Day on September 29, we offer insights to debunk popular assumptions that affect advances in knowledge and improvements in health.
SYDNEY, SEPT 27 - Salt sold in supermarkets and salt shakers in restaurants should be required to carry a front-of-pack, tobacco-style health warning, according to The World Hypertension League and leading international health organisations.